Immunohistochemically detected lymph-node micrometastases in breast cancer and their correlation with prognostic factors

Breast Journal

Volumn 3, Issue 3 SUPPL., 1997, Pages 106-111

  Gerber, Bernd ^a   Krause, Annette ^a   Reimer, Toralf ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Breast cancer; Lymph nodes; Micrometastases; Prognostic factors

Indexed keywords

CATHEPSIN D; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; ONCOPROTEIN; PROGESTERONE RECEPTOR; PROTEIN P53;

ADULT; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER SURVIVAL; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PLOIDY; PROGNOSIS; RECEPTOR DENSITY; SURVIVAL TIME;

EID: 0030906390     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4741.1997.tb00152.x     Document Type: Article

References (20)

1. Robert-Koch-Institut. Cancer incidence in Germany. Geburtsh Frauenheilk 1996;56(4):XI
2. Fisher B, Slack M Katrych D, et al. 10 year follow-up results of patients with carcinoma of the breast in a cooperative clinical trial evaluating surgical adjuvant chemotherapy. Surg Gynecol Obstet 1975;140:528-34.
3. Valagussa B, Bonadonna G, Veronesi U. Patterns of relapse and survival following radical mastectomy. Cancer 1978; 41:1170-8.
4. Bloom HJG, Richardson WW. Histological grading and breast cancer. Br J Cancer 1957;13:359-77.
5. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomized trials involving 31 000 recurrences and 24 000 deaths among 75 000 women. Lancet 1992;339:1-15,71-85.
6. International consensus conference on primary treatment of breast cancer. St. Gallen, Switzerland, March 1-4, 1995.
7. Clark GM. Prognostic and predictive factors. In: Harris JR, Lippmann ME, Morrow M, Hellmann S, eds. Diseases of the Breast. Philadelphia-New York: Lippincott-Raven, 1996: 461-85.
8. de Mascarel I, Bonichon F, Coindre JM, Trojani M. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer 1992;66:523-27.
9. International Ludwig Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 1990;335:1565-68.
10. Neville, AM. Breast cancer micrometastases in lymph node and bone marrow are prognostically important. Ann Oncol 1991;2:13-14.
11. Gerber B, Krause A, Kimmig R. Immunohistochemically detected lymph node micrometastases in nodal negative breast cancer: correlation with "established" and "newer" prognostic factors. Gynäkol Geburtsh Rundsch 1995; 35 (Suppl): 32-35.
12. Trojani MI, de Mascarel F, Bonichon J, Coindre M, Delsol G. Micrometastases to axillary lymph nodes from carcinoma of breast. Detection by immunohistochemistry and prognostic significance. Br J Cancer 1987;55:303-7.
13. Elson CE, Kufe D, Johnston WW. Immunohistochemical detection and significance of axillary lymph node micrometastases in breast carcinoma. A study of 97 cases. Anal Quant Cytol Histol 1993;15:171-78.
14. Fisher ER, Swamidoss S, Lee CH, et al. Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer 1978;42:2025-31.
15. McGuckin MA, Cummings MC, Walsh MD, et al. Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 1996;73:88-95.
16. Sedmak DD, Meineke TA, Knechtges DS. Detection of metastatic breast carcinoma with monoclonal antibodies to cytoceratins. Arch Pathol Lab Med 1989;113:786-89.
17. Rosen PP, Saigo PE, Braun WD, et al. Axillary micro-and macrometastases in breast cancer. Ann Surg 1981;194: 585-91.
18. Schoenfeld A, Luqmani Y, Smith D, et al. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 1994;54:2986-2990.
19. Noguchi S, Aihara T, Nakamori S, et al. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer 1994;74:1595-1600.
20. Noguchi S, Aihara T, Motumura K, et al. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification. Am J Pathol 1996;148:649-56.